Meitheal Pharmaceuticals (Meitheal) is pleased to announce that we have launched Nelarabine Injection, 250 mg per 50 mL, in a single-dose vial.
Meitheal will offer Nelarabine Injection in a carton of 6 vials.
ABOUT NELARABINE INJECTION
Nelarabine Injection is a nucleoside metabolic Inhibitor indicated for the treatment of patients with T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma in adult and pediatric patients age 1 year and older whose disease has not responded to or has relapsed following treatment with at least two chemotherapy regimens link.
Learn more about Nelarabine Injection.